NorthWest Health Prop Real Est Inv Trust (NWH.UN) Stock Price, News & Analysis

Company Overview

Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.

Key Stats

• Today's Range: C$5.54 to C$5.60
• 50-Day Range: C$5.19 to C$6.02
• 52-Week Range: C$4.44 to C$6.07
• Volume: 366,648 shs
• Average Volume: 733,275 shs
• Market Capitalization: C$1.39 billion
• P/E Ratio: N/A
• Dividend Yield: 6.45%
• Price Target: C$6.20
• Consensus Rating: Hold

NorthWest Health Prop Real Est Inv Trust Stock Analysis - MarketRank™

NorthWest Health Prop Real Est Inv Trust scored higher than 49% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Hold

Consensus Rating

NorthWest Health Prop Real Est Inv Trust has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and no sell ratings.

Upside Potential

NorthWest Health Prop Real Est Inv Trust has a consensus price target of C$6.20, representing about 11.1% upside from its current price of C$5.58.

Amount of Analyst Coverage

NorthWest Health Prop Real Est Inv Trust has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of NorthWest Health Prop Real Est Inv Trust is -26.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of NorthWest Health Prop Real Est Inv Trust is -26.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

NorthWest Health Prop Real Est Inv Trust has a PEG Ratio of 0.74. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

NorthWest Health Prop Real Est Inv Trust has a P/B Ratio of 0.78. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for NWH.UN.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

NorthWest Health Prop Real Est Inv Trust is a leading dividend payer. It pays a dividend yield of 6.36%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

NorthWest Health Prop Real Est Inv Trust does not have a long track record of dividend growth.

News and Social Media

• Score: 3.6 / 5
• News Sentiment: N/A

News Sentiment

NorthWest Health Prop Real Est Inv Trust has a news sentiment score of 1.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.84 average news sentiment score of Real Estate companies.

News Coverage This Week

MarketBeat has tracked 1 news article for NorthWest Health Prop Real Est Inv Trust this week, compared to 0 articles on an average week.

MarketBeat Follows

Only 1 people have added NorthWest Health Prop Real Est Inv Trust to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.2 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, NorthWest Health Prop Real Est Inv Trust insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.31% of the stock of NorthWest Health Prop Real Est Inv Trust is held by insiders.

Percentage Held by Institutions

13.17% of the stock of NorthWest Health Prop Real Est Inv Trust is held by institutions.

NWH.UN Stock Analysis - Frequently Asked Questions

How have NWH.UN shares performed this year?

NorthWest Health Prop Real Est Inv Trust's stock was trading at C$5.11 at the beginning of 2026. Since then, NWH.UN stock has increased by 9.2% and is now trading at C$5.58.

How were NorthWest Health Prop Real Est Inv Trust's earnings last quarter?

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) issued its quarterly earnings data on Tuesday, February, 24th. The company reported ($0.16) EPS for the quarter. The firm had revenue of $102.27 million for the quarter. NorthWest Health Prop Real Est Inv Trust had a negative net margin of 75.29% and a negative trailing twelve-month return on equity of 14.67%.
Read the conference call transcript.

How do I buy shares of NorthWest Health Prop Real Est Inv Trust?

Shares of NWH.UN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Company Calendar

• Last Earnings: 2/24/2026
• Today: 5/07/2026

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Real Estate
• Industry: REIT - Healthcare Facilities
• Sub-Industry: N/A
• Current Symbol: TSE:NWH.UN
• CIK: N/A
• Web: www.nwhp.ca
• Phone: +1-416-3662000
• Fax: N/A
• Employees: 213
• Year Founded: N/A

Price Target and Rating

• Average Price Target for NorthWest Health Prop Real Est Inv Trust: C$6.20
• High Price Target: C$7.00
• Low Price Target: C$5.75
• Potential Upside/Downside: +11.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): C($0.21)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 11.37
• P/E Growth: 0.74
• Net Income: -C$394.40 million
• Net Margins: -75.29%
• Pretax Margin: N/A
• Return on Equity: -14.67%
• Return on Assets: 2.91%

Debt

• Debt-to-Equity Ratio: 129.42
• Current Ratio: 0.25
• Quick Ratio: 0.06

Sales & Book Value

• Annual Sales: C$422.53 million
• Price / Sales: 3.28
• Cash Flow: C$0.26 per share
• Price / Cash Flow: 21.67
• Book Value: C$7.14 per share
• Price / Book: 0.78

Miscellaneous

• Outstanding Shares: 248,399,000
• Free Float: N/A
• Market Cap: C$1.39 billion
• Optionable: Not Optionable
• Beta: 1.63